Literature DB >> 9059484

Evaluation of pleural diseases with FDG-PET imaging: preliminary report.

T Bury1, P Paulus, A Dowlati, J L Corhay, P Rigo, M F Radermecker.   

Abstract

BACKGROUND: Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) is an accurate method for differentiating benign from malignant disease. The use of FDG-PET for the aetiological diagnosis of pleural disease was investigated in 25 patients.
METHODS: PET was performed on each subject before invasive procedures were used to determine the aetiological diagnosis. The PET data were analysed by visual interpretation of coronal, sagittal, and transverse slices.
RESULTS: Sixteen patients were found to have malignant pleural disease and nine had benign disease. All patients with histologically confirmed malignant disease showed FDG uptake within the pleural thickening which was intense in 14 cases and moderate in two. PET imaging showed the absence of FDG uptake and correctly categorised seven non-malignant lesions. Two patients with infectious pleural diseases showed a localised and moderate FDG uptake.
CONCLUSION: Our preliminary results suggest that FDG-PET could be an effective tool for differentiating between benign and malignant pleural diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059484      PMCID: PMC1758495          DOI: 10.1136/thx.52.2.187

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  4 in total

1.  CT in differential diagnosis of diffuse pleural disease.

Authors:  A N Leung; N L Müller; R R Miller
Journal:  AJR Am J Roentgenol       Date:  1990-03       Impact factor: 3.959

2.  Evaluation of the solitary pulmonary nodule by positron emission tomography imaging.

Authors:  T Bury; A Dowlati; P Paulus; J L Corhay; T Benoit; J M Kayembe; R Limet; P Rigo; M Radermecker
Journal:  Eur Respir J       Date:  1996-03       Impact factor: 16.671

3.  Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.

Authors:  N A Dewan; N C Gupta; L S Redepenning; J J Phalen; M P Frick
Journal:  Chest       Date:  1993-10       Impact factor: 9.410

4.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.

Authors:  R L Wahl; L E Quint; R L Greenough; C R Meyer; R I White; M B Orringer
Journal:  Radiology       Date:  1994-05       Impact factor: 11.105

  4 in total
  10 in total

1.  Positron emission tomography in mesothelioma patients.

Authors:  Gaia Grassetto; Domenico Rubello
Journal:  Mol Imaging Biol       Date:  2009-03-25       Impact factor: 3.488

2.  Unusual Contiguous Soft Tissue Spread of Advanced Malignant Mesothelioma Detected by FDG PET/CT.

Authors:  Yuyang Zhang; Jamie Edwards; Hadyn Williams; Zhonglin Hao; Samir Khleif; Darko Pucar
Journal:  Nucl Med Mol Imaging       Date:  2016-06-06

Review 3.  [(18)F]-FDG PET and localized fibrous mesothelioma.

Authors:  J Cortes; J Rodriguez; M J Garcia-Velloso; N Rodriguez-Espiteri; J F Boan; J M Castellano; W Torre
Journal:  Lung       Date:  2003       Impact factor: 2.584

4.  Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease.

Authors:  Ayse Mavi; Sandip Basu; Tevfik F Cermik; Muammer Urhan; Mehdi Bathaii; Dhurairaj Thiruvenkatasamy; Mohamed Houseni; Simin Dadparvar; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2009-05-27       Impact factor: 3.488

Review 5.  Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.

Authors:  Kazuhiro Kitajima; Hiroshi Doi; Kozo Kuribayashi
Journal:  Jpn J Radiol       Date:  2016-05-24       Impact factor: 2.374

6.  Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma.

Authors:  V H Gerbaudo; S Britz-Cunningham; D J Sugarbaker; S T Treves
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

7.  Current perspective on the diagnosis of malignant pleural effusion.

Authors:  Jun Hyeok Lim; Jeong-Seon Ryu
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

8.  FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy.

Authors:  Giovenzio Genestreti; Andrea Moretti; Sara Piciucchi; Noemi Giovannini; Riccardo Galassi; Emanuela Scarpi; Marco Angelo Burgio; Dino Amadori; Stefano Sanna; Venerino Poletti; Federica Matteucci; Giampaolo Gavelli
Journal:  J Cancer       Date:  2012-06-01       Impact factor: 4.207

9.  A newly developed pericardial tuberculoma during antituberculous therapy.

Authors:  Sang Min Kim; Sung-Ji Park; Jeong Rang Park; Joon Hyouk Choi; Ji Hyun Yang; Hye Jin Noh; Hyun Chul Jo; Soo Hee Choi; Yeon Hyeon Choe; Seung Woo Park
Journal:  Korean Circ J       Date:  2011-12-31       Impact factor: 3.243

10.  Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.

Authors:  Min-Fu Yang; Zhao-Hui Tong; Zhen Wang; Ying-Yi Zhang; Li-Li Xu; Xiao-Juan Wang; Wan Li; Xiu-Zhi Wu; Wen Wang; Yu-Hui Zhang; Tao Jiang; Huan-Zhong Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-22       Impact factor: 9.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.